Olympus Corp. Hits Day High with Strong 3.27% Intraday Surge
Olympus Corp. has experienced significant stock activity, achieving an intraday high and outperforming the Japan Nikkei 225 over the past week. Despite a year-to-date decline, the company maintains strong fundamentals, including a solid Return on Equity and positive operating cash flow for three consecutive quarters.
Olympus Corp., a prominent player in the Pharmaceuticals & Biotechnology sector, has shown notable activity today, gaining 3.27% on October 22, 2025. The stock reached an intraday high of JPY 1,959.50, reflecting a positive shift in its performance metrics. In comparison to the Japan Nikkei 225, which rose by 0.27% on the same day, Olympus Corp. has outperformed the index over the past week, with a 7.89% increase compared to the Nikkei's 5.27%. However, the stock's performance over the longer term reveals a more complex picture, with a year-to-date decline of 17.49% and a significant drop of 31.02% over the past year.
Despite these challenges, Olympus Corp. has demonstrated strong long-term fundamentals, highlighted by an average Return on Equity (ROE) of 18.96% and a low Debt to EBITDA ratio of 0.43 times. The company has also reported positive results for the last three consecutive quarters, with operating cash flow reaching JPY 152,003 million. As Olympus Corp. continues to navigate the market, its current performance metrics indicate a resilient position within its industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
